TRIM33 and cancer: In contrast to the anti-TIF1-γ- or NXP2 (nuclear matrix protein 2)-related myopathies that are known to be associated with malignancies (22, 23), the association of anti-MDA5 disease with cancer has only been reported in a few case reports (3).